Zura Bio Ltd has a consensus price target of $16.5, established from looking at the 7 latest analyst ratings. The last 3 analyst ratings were released from Oppenheimer, Ladenburg Thalmann, and Oppenheimer on April 1, 2024, October 10, 2023, and August 25, 2023. With an average price target of $14.33 between Oppenheimer, Ladenburg Thalmann, and Oppenheimer, there's an implied 222.10% upside for Zura Bio Ltd from these 3 analyst ratings.
1calculated from analyst ratings published within the last 3 years
date | ticker | Buy Now | Company | Current price | Upside/Downside | Analyst Firm | Analyst & % Accurate | Price Target Change | Rating Change | Previous / Current Rating | Get Alert |
---|---|---|---|---|---|---|---|---|---|---|---|
04/01/2024 | ZURA | Buy Now | Zura Bio | $4.45 | 259.55% | Oppenheimer | Jeff Jones | $17 → $16 | Reiterates | Outperform → Outperform | Get Alert |
10/10/2023 | ZURA | Buy Now | Zura Bio | $4.45 | 124.72% | Ladenburg Thalmann | Aydin Huseynov | → $10 | Initiates | → Buy | Get Alert |
08/25/2023 | ZURA | Buy Now | Zura Bio | $4.45 | 282.02% | Oppenheimer | Justin Kim | → $17 | Initiates | → Outperform | Get Alert |
08/15/2023 | ZURA | Buy Now | Zura Bio | $4.45 | 394.38% | Raymond James | Steven Seedhouse | $20 → $22 | Maintains | Strong Buy | Get Alert |
06/22/2023 | ZURA | Buy Now | Zura Bio | $4.45 | 349.44% | Guggenheim | Yatin Suneja | → $20 | Initiates | → Buy | Get Alert |
06/14/2023 | ZURA | Buy Now | Zura Bio | $4.45 | 214.61% | Chardan Capital | Matthew Barcus | → $14 | Initiates | → Buy | Get Alert |
05/24/2023 | ZURA | Buy Now | Zura Bio | $4.45 | 349.44% | Raymond James | Steven Seedhouse | → $20 | Initiates | → Strong Buy | Get Alert |
The latest price target for Zura Bio (NASDAQ: ZURA) was reported by Oppenheimer on April 1, 2024. The analyst firm set a price target for $16.00 expecting ZURA to rise to within 12 months (a possible 259.55% upside). 7 analyst firms have reported ratings in the last year.
The latest analyst rating for Zura Bio (NASDAQ: ZURA) was provided by Oppenheimer, and Zura Bio reiterated their outperform rating.
There is no last upgrade for Zura Bio.
There is no last downgrade for Zura Bio.
Analysts arrive at stock ratings after doing extensive research, which includes going through public financial statements, talking to executives and customers of Zura Bio, and listening in to earnings conference calls. Most analysts do this every three months, so you should get 4 ratings per company per firm each year. The last rating for Zura Bio was filed on April 1, 2024 so you should expect the next rating to be made available sometime around April 1, 2025.
While ratings are subjective and will change, the latest Zura Bio (ZURA) rating was a reiterated with a price target of $17.00 to $16.00. The current price Zura Bio (ZURA) is trading at is $4.45, which is out of the analyst’s predicted range.
Browse analyst ratings and price targets on all stocks.